NON-PROLIFERATIVE DIABETIC RETINOPATHY
Clinical trials for NON-PROLIFERATIVE DIABETIC RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY trials appear
Sign up with your email to follow new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ANXV aims to save sight in diabetic eye disease and vein blockages
Disease control Recruiting nowThis early study tests a new drug, ANXV, in 12 adults with diabetic retinopathy or retinal vein occlusion. Participants receive five daily infusions over 4 months to check safety and whether it improves vision. The goal is to find the right dose for larger studies.
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Annexin Pharmaceuticals AB • Aim: Disease control
Last updated May 17, 2026 13:58 UTC
-
New eye implant could slow Diabetes-Related vision loss
Disease control Recruiting nowThis study tests an eye implant that slowly releases medicine to treat non-proliferative diabetic retinopathy, a common diabetes complication that can lead to vision loss. About 930 adults with moderate to severe disease will receive either the implant or a sham procedure. The go…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE3 • Sponsor: Ocular Therapeutix, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC